CalciMedica Subsidiary, Inc.
LA JOLLA, CA · Founded 2006 · CIK 0001385359 · Biotech · Public
Small-molecule CRAC channel inhibitor drug candidates for inflammatory diseases
calcimedica.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $67M
- 9 Form D · Apr 2023
- 42 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $9,000,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $13,200,000 | |
| Private capital raised | Form D · SEC | $4,600,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $2,499,999 | |
| Private capital raised | Form D · SEC | $17,194,272 | |
| Private capital raised | Form D · SEC | $10,340,663 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1131 | Denali Therapeutics | — | $500M |
| 1132 | MS Biotech Holdings, Inc. | — | $59M |
| 1133 | PROLACTA BIOSCIENCE INC | — | $65M |
| 1134 | CalciMedica Subsidiary, Inc. | — | $67M |
| 1135 | Vergent Bioscience, Inc. | — | $54M |
| 1136 | REGENOSINE INC | — | — |
| 1137 | Synata Bio, Inc. | — | $52M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Lakmir ChawlaDirector
- Michael DiemDirector
- Michael DunnDirector · Executive Officer
- Brian GallagherDirector
- Daniel GeffkenExecutive Officer
- Kent GossettDirector
- Vikas GoyalDirector
- Evelyn GrahamDirector
- Sudarshan HebbarExecutive Officer
- A. LehenyDirector · Executive Officer
- John McDonaldDirector
- Robert McNeilDirector
- Peter McWilliamsDirector
- Fred MiddletonDirector
- Eric RobertsDirector · Executive Officer
- Ken StaudermanExecutive Officer
- Kenneth StaudermanExecutive Officer
- Gonul VelicelebiDirector · Executive Officer
- Robert WilsonDirector
- Timothy WollaegerDirector
- Gordon WongDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.